The Future of Medicine

Developing New Categories of Medicine

Our goal is to improve and extend the lives of patients through the development of breakthrough medicine

Exploring the Brain Immune Gut (BIG) Axis

PureTech Health is pioneering the development of therapeutics based on the crosstalk and biology of the brain-immune-gut axis

Giving Life to Science

Our goal is to improve and extend the lives of patients

The biopharma company of the future

Discovery Reinvented

Publications
Publications -2018-03-23
PureTech's Lymphatic Leap

PureTech Health plc is launching a new branch of inquiry into the lymphatic system following discoveries that the network extends into the brain and could be used to deliver immunotherapies directly to tissues.

FULL ARTICLE

Publications -2017-09-19
Gamma Delta T Cells Support Pancreatic Oncogenesis by Restraining αβ T Cell Activation

CD4(+) T regulatory cells (T(regs)), which express the Foxp3 transcription factor, play a critical role in the maintenance of immune homeostasis. Here, we show that in mice, T(regs) were most abundant in the colonic mucosa.

Full Article

Publications -2017-09-19
The Gut’s Clostridium Cocktail

Specific components of the microbiota—the microorganisms that normally colonize the body—can affect disease progression in mouse models of arthritis, central nervous system inflammation, diabetes, intestinal inflammation, and obesity.

Full Article
Press releases
2018-06-19
PureTech’s Karuna Receives $8 Million Wellcome Trust Award to Advance Phase 2 Product Candidate for the Treatment of Schizophrenia

Continue

Press releases
2018-06-05
PureTech’s Gelesis Appoints Harry Leider, former Walgreens Chief Medical Officer, as Chief Medical Officer and Paul Fonteyne, Chairman and Former CEO of Boehringer Ingelheim USA, to Board of Directors

Appointments bring strong track records of leadership and experience in commercial launches and medical affairs

PureTech Health plc (LSE: PRTC) ("PureTech Health"), an advanced, clinical-stage biopharmaceutical company, announced today that its affiliate, Gelesis, has appointed Harry Leider, MD, MBA, former Chief Medical Officer and Group Vice President of Walgreens, as Chief Medical Officer. Gelesis also announced the appointment of Paul Fonteyne, Chairman and former CEO of Boehringer Ingelheim USA, to the Board of Directors.

Continue

Press releases
2018-05-30
PureTech Health to Present at Jefferies 2018 Global Healthcare Conference

PureTech Health plc (LSE: PRTC) ("PureTech Health"), an advanced, clinical-stage biopharmaceutical company, announced today that Joep Muijrers, PhD, Chief Financial Officer at PureTech Health, will present at the Jefferies 2018 Global Healthcare Conference in New York City on Wednesday, 6 June, at 9:30AM EDT.

Continue